TM) in Japan ...
Smith & Nephew Receives C1 Category Reimbursement Approval for OXINIUMPR Newswire via Yahoo! Finance: 4 views since Wednesday, September 3, 2008 at 10:00 AM
Smith & Nephew, Inc. Orthopaedic Reconstruction & Trauma business and Smith & Nephew Orthopaedics KK Japan today announced that it has received Japanese regulatory C1 Category Reimbursement approval for it's award winning OXINIUM oxidized zirconium technology.

Published in: Procedures and Therapies